FR2340321A1 - Composes a cycle b-lactame utilisables comme medicament pour renforcer l'efficacite des antibiotiques contre des bacteries productrices de b-lactamase - Google Patents

Composes a cycle b-lactame utilisables comme medicament pour renforcer l'efficacite des antibiotiques contre des bacteries productrices de b-lactamase

Info

Publication number
FR2340321A1
FR2340321A1 FR7702856A FR7702856A FR2340321A1 FR 2340321 A1 FR2340321 A1 FR 2340321A1 FR 7702856 A FR7702856 A FR 7702856A FR 7702856 A FR7702856 A FR 7702856A FR 2340321 A1 FR2340321 A1 FR 2340321A1
Authority
FR
France
Prior art keywords
lactamase
effectiveness
enhance
compounds
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7702856A
Other languages
English (en)
Other versions
FR2340321B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of FR2340321A1 publication Critical patent/FR2340321A1/fr
Application granted granted Critical
Publication of FR2340321B1 publication Critical patent/FR2340321B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR7702856A 1976-02-04 1977-02-02 Composes a cycle b-lactame utilisables comme medicament pour renforcer l'efficacite des antibiotiques contre des bacteries productrices de b-lactamase Granted FR2340321A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB4320/76A GB1529913A (en) 1976-02-04 1976-02-04 Beta-lactam compounds
GB859776 1976-03-04
GB1534676 1976-04-14
GB2422776 1976-06-11

Publications (2)

Publication Number Publication Date
FR2340321A1 true FR2340321A1 (fr) 1977-09-02
FR2340321B1 FR2340321B1 (fr) 1980-03-07

Family

ID=27447370

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7702856A Granted FR2340321A1 (fr) 1976-02-04 1977-02-02 Composes a cycle b-lactame utilisables comme medicament pour renforcer l'efficacite des antibiotiques contre des bacteries productrices de b-lactamase

Country Status (15)

Country Link
US (1) US4206120A (fr)
JP (1) JPS5297994A (fr)
AT (1) AT352875B (fr)
AU (1) AU506250B2 (fr)
BE (1) BE850942A (fr)
CH (1) CH636357A5 (fr)
DE (1) DE2704104A1 (fr)
DK (1) DK46677A (fr)
ES (1) ES455625A1 (fr)
FR (1) FR2340321A1 (fr)
GB (1) GB1529913A (fr)
IE (1) IE44460B1 (fr)
IL (1) IL51339A (fr)
NL (1) NL7701191A (fr)
SE (1) SE7701216L (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2368489A1 (fr) * 1976-10-22 1978-05-19 Glaxo Lab Ltd Derives de la clavuline, leur procede de preparation et leur application en therapeutique
EP0002319A1 (fr) * 1977-11-29 1979-06-13 Beecham Group Plc Dérivés de l'acide clavulanique, procédé pour leur préparation et compositions les contenant
EP0002574A1 (fr) * 1977-12-08 1979-06-27 Beecham Group Plc Dispersions sous forme de particules, procédé pour leur fabrication et compositions pharmaceutiques les contenant
USRE38796E1 (en) 1995-11-17 2005-09-13 Ajinomoto Co.,Inc. Process for producing 3-amino-2-oxo-1-halogenopropane derivatives
US9120808B2 (en) 2009-09-15 2015-09-01 Nabriva Therapeutics Ag Substituted clavulanic acid

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136132A (fr) * 1975-02-17 1982-11-23 Teruji Tsuji Cyclisation pour fermer des noyaux cephem et intermediaires ainsi obtenus
EP0000615B1 (fr) * 1977-07-23 1981-04-29 Beecham Group Plc Composés béta-lactame, préparation et utilisation dans compositions pharmaceutiques et comme produits chimiques intermédiaires
EP0024372A1 (fr) * 1979-08-03 1981-03-04 Beecham Group Plc Dérivés de l'acide clavulanique, leur préparation et compositions pharmaceutiques les contenant
EP0025287A1 (fr) * 1979-08-21 1981-03-18 Beecham Group Plc Dérivés de l'acide clavulanique, leur préparation, compositions pharmaceutiques les contenant et leur préparation
US4562182A (en) * 1980-12-23 1985-12-31 Beecham Group P.L.C. Compounds containing beta-lactams
EP0057664A3 (fr) * 1981-01-30 1982-11-17 Ciba-Geigy Ag Dérivés de clavame
DE3725375A1 (de) * 1987-07-31 1989-02-09 Bayer Ag Stabile oxapenem-3-carbonsaeuren
GB9421816D0 (en) * 1994-10-29 1994-12-14 Smithkline Beecham Plc Novel compounds
FR2739851B1 (fr) 1995-10-13 1997-11-21 Oreal Nouveaux derives alkyl-3-oxo-alcanoates et leur procede de preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1542405A (en) * 1975-04-15 1979-03-21 Beecham Group Ltd Clavulanic acid derivatives

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2368489A1 (fr) * 1976-10-22 1978-05-19 Glaxo Lab Ltd Derives de la clavuline, leur procede de preparation et leur application en therapeutique
EP0002319A1 (fr) * 1977-11-29 1979-06-13 Beecham Group Plc Dérivés de l'acide clavulanique, procédé pour leur préparation et compositions les contenant
EP0002574A1 (fr) * 1977-12-08 1979-06-27 Beecham Group Plc Dispersions sous forme de particules, procédé pour leur fabrication et compositions pharmaceutiques les contenant
USRE38796E1 (en) 1995-11-17 2005-09-13 Ajinomoto Co.,Inc. Process for producing 3-amino-2-oxo-1-halogenopropane derivatives
US9120808B2 (en) 2009-09-15 2015-09-01 Nabriva Therapeutics Ag Substituted clavulanic acid

Also Published As

Publication number Publication date
FR2340321B1 (fr) 1980-03-07
US4206120A (en) 1980-06-03
DK46677A (da) 1977-05-16
AU506250B2 (en) 1979-12-20
AT352875B (de) 1979-10-10
JPS5297994A (en) 1977-08-17
GB1529913A (en) 1978-10-25
NL7701191A (nl) 1977-08-08
IL51339A0 (en) 1977-03-31
CH636357A5 (de) 1983-05-31
DE2704104A1 (de) 1977-08-11
ATA65177A (de) 1979-03-15
SE7701216L (sv) 1977-08-05
BE850942A (fr) 1977-08-01
AU2193177A (en) 1978-08-10
IL51339A (en) 1980-03-31
IE44460L (en) 1977-08-04
ES455625A1 (es) 1978-05-16
IE44460B1 (en) 1981-12-02

Similar Documents

Publication Publication Date Title
BE866845A (fr) Composes thia-aza a noyau beta-lactame utiles notamment comme medicaments
FR2340321A1 (fr) Composes a cycle b-lactame utilisables comme medicament pour renforcer l'efficacite des antibiotiques contre des bacteries productrices de b-lactamase
BE826440A (fr) Nouveaux 2-tetrahydrofurfuryl-6,7-benzomorphanes, leurs sels d'addition avec des acides, leurs utilisation comme medicament et leur procede de fabrication
BE854102A (fr) Derives de desamination de l'inhibiteur de trypsinekallikreine, procede pour leur production et leur application comme medicament
GB2011900A (en) N'-substituted -aminoalkanoyl- -aminoalkanoic acids their use and process for their production as well as pharmaceutical products containing these compounds
IE45439L (en) Penicillanic acid derivatives
LU79494A1 (fr) Procede de preparation de composes a cycle b-lactame,utilisables comme medicament
KE2977A (en) Improvements relating to the growing of seedlings
LU79356A1 (fr) Preparation d'interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments
BE811680A (fr) Perfectionnements relatifs a la preparation d'un produit enzymatique
IE38373L (en) N,n-dimethyl-o-triazolyl-carbamic acid esters; insecticides
FR2356642B1 (fr) La 2-bromo-6-fluoro-n-2-imidazolinylidene-benzamine, ses sels d'addition avec des acides, procedes pour leur preparation et les medicaments les renfermant
BE816869R (fr) Medicament utile notamment pour l'irrigation cerebrale
FR2340093A1 (fr) Derives de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
PT69674A (pt) Procede de preparation d'un medicament contre les maladiesinfectieuses des voies respiratoires
FR2336134A1 (fr) Derives trifluoromethylthio de cyproheptadine utiles comme medicament
FR2346019A1 (fr) Composition utile comme medicament pour eliminer ou reduire l'envie de fumer
JPS53126063A (en) Production of chitin derivative
ZA787367B (en) Acylhydrocarbylaminoalkanoic acids,their production and use as well as pharmaceutical products containing same
IE40172B1 (en) New acylamino-phenyl-acetamidine compounds,their production, and their medicinal use
FR2282271A1 (fr) Sels d'amoxycilline, utiles comme medicaments
FR2387228A1 (fr) Nouveaux 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7-benzomorphanes, leurs sels d'addition avec des acides, leur preparation et medicaments les renfermant
BE811247A (fr) Procede de preparation d'un d-maleate de rotoxamine et medicament obtenu
PT70367A (en) Process for the preparation of 4,4-dimethyl-4-sila-fatty acid amides with pharmaceutical effect
IE39225B1 (en) Penicillins processes for their preparation and their use as medicaments

Legal Events

Date Code Title Description
ST Notification of lapse